Bilal Arif
Chief Tech/Sci/R&D Officer at SAREPTA THERAPEUTICS, INC.
Net worth: 3 M $ as of 30/03/2024
Profile
Bilal Arif is currently the Chief Technical Operations Officer & Executive VP at Sarepta Therapeutics, Inc. Previously, he worked as the Vice President-Technical Operations at Momenta Pharmaceuticals, Inc. from 2017 to 2019.
Mr. Arif completed his undergraduate degree at McGill University, his graduate degree at Tufts University, and his MBA at Instituto de Empresa SL.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 07/03/2024 | 25,222 ( 0.03% ) | 3 M $ | 30/03/2024 |
Bilal Arif active positions
| Companies | Position | Start |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 30/12/2022 |
Former positions of Bilal Arif
| Companies | Position | End |
|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2019 |
Training of Bilal Arif
| McGill University | Undergraduate Degree |
| Tufts University | Graduate Degree |
| Instituto de Empresa SL | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Bilal Arif
